Ono Pharmaceutical Co (MEX:4528N) OCF Margin %: 42.26% (As of Mar. 2026) — 80% Above Median


MEX:4528N Ono Pharmaceutical Co Ltd MEX:4528N
88 GF Score
Price MXN341.69
GF Value MXN324.16
! 2 Warning Signs
View Full Analysis

What is Ono Pharmaceutical Co OCF Margin %?

Ono Pharmaceutical Co MEX:4528N 88 OCF Margin % is 42.26% as of Mar. 2026, which is 80% above its 10-year median of 23.53. GuruFocus rates MEX:4528N with a GF Score™ of 88/100 and a GF Value™ of MXN324.16. The stock has 2 warning signs investors should review. Among 956 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 88.81% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Ono Pharmaceutical Co's Cash Flow from Operations for the three months ended in Mar. 2026 was MXN5,703 Mil. Ono Pharmaceutical Co's Revenue for the three months ended in Mar. 2026 was MXN13,495 Mil. Therefore, Ono Pharmaceutical Co's OCF Margin % for the quarter that ended in Mar. 2026 was 42.26%.

As of today, Ono Pharmaceutical Co's current OCF Yield % is 12.25%.

The historical rank and industry rank for Ono Pharmaceutical Co's OCF Margin % or its related term are showing as below:

MEX:4528N' s OCF Margin % Range Over the Past 10 Years
Min: 6.01   Med: 23.53   Max: 35.69
Current: 25.89


During the past 13 years, the highest OCF Margin % of Ono Pharmaceutical Co was 35.69%. The lowest was 6.01%. And the median was 23.53%.

MEX:4528N's OCF Margin % is ranked better than
88.81% of 956 companies
in the Drug Manufacturers industry
Industry Median: 9.985 vs MEX:4528N: 25.89


Ono Pharmaceutical Co OCF Margin % Related Terms


Ono Pharmaceutical Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for Ono Pharmaceutical Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co OCF Margin % Chart

Ono Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.11 35.69 22.01 16.94 26.53

Ono Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.72 2.64 39.50 22.93 42.26

MEX:4528N vs LLY, JNJ, ABBV: OCF Margin % Comparison

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's OCF Margin % falls into.


MEX:4528N
88GF Score
Ono Pharmaceutical Co Ltd MEX:4528N
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ono Pharmaceutical Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Ono Pharmaceutical Co's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=15548.337/58613.801
=26.53 %

Ono Pharmaceutical Co's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=5702.682/13494.635
=42.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 42.26% mean?
Ono Pharmaceutical Co (MEX:4528N) has a OCF Margin % of 42.26% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ono Pharmaceutical Co and its competitors. This is 80% above median its historical median of 23.53. Over the past decade, Ono Pharmaceutical Co's OCF Margin % has ranged from 6.01 to 35.69. According to the industry distribution chart, Ono Pharmaceutical Co ranks #107 out of 956 companies in the Drug Manufacturers industry, placing it in the top 11.2%.
Is Ono Pharmaceutical Co's OCF Margin % too high?
Ono Pharmaceutical Co's current OCF Margin % of 42.26% is 80% above median its 10-year median of 23.53. Over the past 10 years, this metric has ranged from a low of 6.01 to a high of 35.69. The Drug Manufacturers industry median OCF Margin % is 9.99. Ono Pharmaceutical Co's value of 42.26% is 323.2% above this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #107 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Ono Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's OCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #107 out of 956 companies for OCF Margin %. This places Ono Pharmaceutical Co in the top 11% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.99. Ono Pharmaceutical Co's value of 42.26% is 323.2% above this benchmark. Historically, Ono Pharmaceutical Co's own OCF Margin % has ranged from 6.01 to 35.69 over the past decade. While the company's 10-year median is 23.53 vs. the industry median of 9.99, Ono Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current OCF Margin % of 42.26% is 323.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current OCF Margin % is 42.26%, which is 80% above median its own 10-year median of 23.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current OCF Margin % of 42.26%. The stock's GF Value™ is MXN324.16, compared to a current price of MXN341.69 — trading 5.4% above its estimated fair value. The current OCF Margin % is 42.26%, which is 80% above median its 10-year median of 23.53 and 323.2% above the Drug Manufacturers industry median of 9.99. Ono Pharmaceutical Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current OCF Margin % is 42.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?

Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN341.69 is trading 5.4% above its estimated GF Value™ of MXN324.16.

Key valuation signals for MEX:4528N:

  • OCF Margin %: 42.26% (80% above median its 10-year median of 23.53)
  • GF Value™: MXN324.16 vs. price of MXN341.69 (5.4% above fair value)
  • GF Score™: 88/100 with 2 warning signs
  • Industry Position: 323.2% above the Drug Manufacturers median (#107 of 956)

No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ono Pharmaceutical Co Business Description

Address 1-8-2 Kyutarocho, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
88GF Score

Get the complete analysis for MEX:4528N

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN341.69
Price
MXN324.16
GF Value